- Lobbying
- Steve AND Irizarry
Lobbying Arrangements Results for 'Steve Irizarry'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to reimbursement under Medicare Part D H.R. 5074, the Kidney PATIENT Act |
Ardelyx, Inc.
|
Roberti Global (fka Roberti White, LLC) | |||
Details General Pharmaceutical Issues pertaining to the company. No specific legislation General healthcare issues related to pharmaceutical products. No specific legislation |
DFB Pharmaceuticals, Inc.
|
CAPITOL HILL CONSULTING GROUP | |||
Details S. 1082 Food and Drug Administration Revitalization Act H.R. 2900 Food and Drug Administration Amendments Act of 2007 |
Astellas Pharma, Inc
Pharmaceuticals |
ML STRATEGIES, LLC | |||
Details OFAC licensing issues |
Mare Finance Investment Holdings
|
Roberti Global (fka Roberti White, LLC) | |||
Details Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplanation; Patient Protection and Affordable Care Act (P.L. 111-148); Prescription Drug... |
Astellas Pharma US
Pharmaceutical company |
CAPITOL HILL CONSULTING GROUP | |||
Details legislative and regulatory issues related to independent pharmacy and pharmacy benefit managers (PBMs). H.R. 1613/S. 1038, Drug Price Transparency in Medicaid Act H.R. 2816, PBM Sunshine and Accoun... |
American Pharmacies, Inc.
|
Roberti Global (f/k/a Roberti White, LLC) | |||
Details H.R. 3630, The Middle Class Tax Relief and Job Creation Act of 2011, Medicare provisions Medicare payment for Intraoperative Radiation Therapy |
Carl Zeiss, Inc.
|
Roberti White LLC | |||
Details General health care issues related to the pharmaceutical and biological products; Federal Food, Drug, and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A) General Medicare and Medicai... |
ELI LILLY AND COMPANY
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to Medicare Part B coverage and reimbursement, generally Issues related to Medicare Part D, generally Issues related to drug pricing, value, and transparency, generally Issues involv... |
AMGEN
|
Roberti Global (fka Roberti White, LLC) | |||
Details General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Chil... |
MCBRIDE CLINIC
|
CAPITOL HILL CONSULTING GROUP | |||
Details Outreach and monitoring relating to technology issues, including 5G, spectrum and wireless broadband, affecting the telecommunications industry. Outreach and monitoring related to appropriations i... |
Samsung Electronics America, Inc.
|
Roberti Global (fka Roberti White, LLC) | |||
Details Reimbursement of outpatient medical imaging services provided under Medicare Part B. Healthcare reform legislation, generally; American's Affordable Health Choices Act (H.R. 3200) |
CSCM, Inc.
|
CAPITOL HILL CONSULTING GROUP | |||
Details General healthcare issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Food and Drug Administration Act... |
PHRMA
|
CAPITOL HILL CONSULTING GROUP | |||
Details Assist the NKF in securing federal funding for programs aimed at screening and preventing chronic kidney disease; Requesting funding for the Kidney Early Evaluation Program (KEEP) Assist the NKF in... |
National Kidney Foundation
Health Organization dedicated to the prevention of kidney disease |
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). Al... |
International Academy of Compounding Pharmacists (IACP)
|
in-house lobbying | |||
Details Implementation of Tax Reform, international tax proposals related to intellectual property. Issues related to Biosimilar Approvals and implementation of biologic price competition and innovation ac... |
NOVARTIS CORPORATION
|
CAPITOL HILL CONSULTING GROUP | |||
Details Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceu... |
PURDUE PHARMA, LLP
|
CAPITOL HILL CONSULTING GROUP | |||
Details General health care issues pertaining to OSU-CHS; NIH. General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education and reauthorizatio... |
Oklahoma State University Center for Health Sciences
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the F... |
Endo Pharmaceuticals
|
CAPITOL HILL CONSULTING GROUP |